["{\"step_by_step_thinking\": \"The question asks about the best results of pneumococcal vaccine PCV 23 polysaccharide. The documents provided discuss various groups of people who were tested with this vaccine. Children over 2 years of age responded well to the vaccine, but younger children may not respond satisfactorily to some capsular types. Adults showed a highly significant reduction in the rates for pneumococcal pneumonias caused by the capsular types present in the vaccine. HIV-infected subjects with greater than 500 CD4 cells and healthy controls also responded well to the vaccine. Therefore, it can be concluded that the best results of this vaccine are seen in adults and children over 2 years of age.\", \"answer_choice\": \"D\"}"]